Overall, middle-income markets in Asia and Latin America are emerging as key drivers of global market expansion as treatment access improves and physician familiarity with GLP-1 medications increases
Elevation of nitric oxide production in human trabecular meshwork by increased pressure
Liposomal glutathione may offer better absorption and effectiveness compared to traditional oral forms
Therefore, treatments targeting MMPs offer a promising approach to this problem and, in recent years, there have been major developments in MMP-targeted treatment related to the genetic background, including the discovery of new synthetic and natural molecules, and potential biomarkers
Compounded injectables, while more affordable, may vary in quality and effectiveness due to less stringent manufacturing processes
These are rare at therapeutic doses and usually indicate the dose needs adjustment